ACTIVATION OF CD4 CELLS BY FIBRONECTIN AND ANTI-CD3 ANTIBODY - A SYNERGISTIC EFFECT MEDIATED BY THE VLA-5 FIBRONECTIN RECEPTOR COMPLEX

被引：330
|
作者：
MATSUYAMA, T
YAMADA, A
KAY, J
YAMADA, KM
AKIYAMA, SK
SCHLOSSMAN, SF
MORIMOTO, C
机构：
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115
[2] BRIGHAM & WOMENS HOSP,DEPT RHEUMATOL & IMMUNOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[4] NCI,MOLEC BIOL LAB,MEMBRANE BIOCHEM LAB,BETHESDA,MD 20894
[5] HOWARD UNIV,CTR CANC,DEPT BIOCHEM,WASHINGTON,DC 20060
[6] HOWARD UNIV,CTR CANC,DEPT ONCOL,WASHINGTON,DC 20060
来源：
JOURNAL OF EXPERIMENTAL MEDICINE | 1989年 / 170卷 / 04期
关键词：
D O I：
10.1084/jem.170.4.1133
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1133 / 1148
页数：16
相关论文
共 50 条
  • [41] Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4+ T cells
    S-J Lin
    P-J Cheng
    S-S Hsiao
    Bone Marrow Transplantation, 2006, 37 : 881 - 887
  • [42] FIBRONECTIN AUGMENTS ANTI-CD3-MEDIATED IL-2 RECEPTOR (CD25) EXPRESSION ON HUMAN PERIPHERAL-BLOOD LYMPHOCYTES
    CARDARELLI, PM
    YAMAGATA, S
    SCHOLZ, W
    MOSCINSKI, MA
    MORGAN, EL
    CELLULAR IMMUNOLOGY, 1991, 135 (01) : 105 - 117
  • [43] Anti-CD3 activation of human CD4+ T cells increases expression of the intracellular β-endorphin endopeptidase (IDE/γ-EpGE)
    Sarada, B
    Thiele, D
    Dang, T
    Lee, J
    Safavia, A
    Hersh, LB
    Cottam, GL
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (01) : 59 - 68
  • [44] Oral administration of anti-CD3 antibody suppresses experimental allergic encephalomyelitis by inducing CD4+CD25-LAP+ regulatory T cells
    Ochi, Hirofumi
    Abraham, Michal
    Ishikawa, Hiroki
    Frenkel, Dan
    Yang, Kaiyong
    Basso, Alexandre
    Wu, Henry
    Chen, Mei-Ling
    Gandhi, Roopali
    Miller, Ariel
    Maron, Ruth
    Weiner, Howard L.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 120 - 121
  • [45] ACTIVATION OF HIV FROM PATIENTS CD4+ T-CELLS BY ANTI-CD3 AND EFFECTS OF TNF-ALPHA
    ZARLING, J
    MORAN, P
    SIAS, J
    DIEGLE, M
    HAFFAR, O
    LEDBETTER, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 339 - 339
  • [46] Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells
    Liao, KW
    Lo, YC
    Roffler, SR
    GENE THERAPY, 2000, 7 (04) : 339 - 347
  • [47] Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells
    K-W Liao
    Y-C Lo
    S R Roffler
    Gene Therapy, 2000, 7 : 339 - 347
  • [48] Oral Anti-CD3 antibody treatment induces CD4+LAP+ regulatory T cells and ameliorates the development of atherosclerosis in mice
    Sasaki, Naoto
    Yamashita, Tomoya
    Tawa, Hideto
    Takeda, Masafumi
    Masano, Tomoya
    Shinohara, Masakazu
    Toh, Ryuji
    Kobayashi, Seirm
    Hirata, Ken-Ichi
    CIRCULATION, 2007, 116 (16) : 146 - 146
  • [49] INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES HAVE NO EFFECT ON ANTI-CD3 MONOCLONAL ANTIBODY-MEDIATED CYTOTOXICITY IN CD3+ LEUKEMIC LARGE ANTIGRANULOCYTES LYMPHOCYTES
    YOON, HJ
    APRILE, JA
    LOUGHRAN, TP
    CELLULAR IMMUNOLOGY, 1990, 131 (02) : 404 - 408
  • [50] Effect of interleukin-15 on anti-CD3/anti-CD28 induced apoptosis of umbilical cord blood CD4+ T cells
    Lin, SJ
    Yu, JC
    Cheng, PJ
    Hsiao, SS
    Kuo, ML
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (06) : 425 - 432
12345